Astellas Pharma : Patient centricity at Astellas—all about action

"At the end of any discussion on patient centricity, you tend to get to a, 'why' or 'so what?' That's a great topic, but what's meaningful about it?" These are questions that Anthony Yanni, a primary care physician, MBA, Astellas' Senior Vice President and Global Head of Patient Centricity has heard often. Discussions on advancing patient-centric cultures abound across the industry but turning talk into meaningful action is essential to effect real change for companies and the patients they serve.

For Astellas, patient centricity is not about buzzwords and grand statements; it is about action. It is about robust practices and a fundamental understanding of real-world settings. It involves crafting processes and capabilities that enable Astellas to deliver. It is about reaching a stage where the voices of both patients and researchers are equally represented during the drug development process.

Astellas' patient centricity vision-to support the development of innovative health solutions through a deep understanding of the patient experience, medical needs, and behavioral drivers of care-is not just a convenient statement. It is a guiding principle for action, which supports the company's corporate strategy.